<DOC>
	<DOCNO>NCT02746432</DOCNO>
	<brief_summary>Research Problem : Surgical stress induces inflammation postoperative immuno-suppression , risk . factor post-operative complication possible disease recurrence . Colorectal cancer top 5 malignancy Kingdome high incidence male . Recurrent disease locally distally occur 35 % patient lead cause death patient . Despite new era laparoscopic surgery , still surgical stress present equally traumatic conventional open colorectal resection , early study show major difference post-operative inflammatory immunological reaction . The previous study reveal anti-inflammatory effect hyper-insulinimic euglycemic therapy . Benefits observe major liver resection cardiac surgery . The anti-inflammatory effect reduce surgical stress postoperative inflammation . The hypothesis `` Can intraoperative hyper-insulinimic euglycemic infusion reduce post operative inflammation immunomodulation colon cancer patient undergo curative surgery ? '' Research methodology Triple blind randomize control study estimate sample size 144 patient non-metastatic colorectal cancer patient operate King Saud University Medical city confirm diagnosis colon adenocarcinoma . Patients Consented undergo computer randomization receive intraoperative hyper-insulinimic normoglycemic infusion ( experimental ) standardize insulin slide scale saline ( control ) . A common preoperative postoperative pathway standardize management pain control group . Outcomes measured via battery laboratory test consist routine lab , inflammatory marker immunological marker repeat fix timed interval . All patient follow regularly 5 year . Research objectives Primary outcome examine : - The anti-inflammatory effect intraoperative hyper-insulinimic euglycemic therapy patient undergoing colorectal cancer surgery . - The immunomodulatory effect intraoperative hyper-insulinimic euglycemic infusion Secondary outcome : - Thirty day post-operative morbidity . - Overall survival rate . - Disease-free survival rate .</brief_summary>
	<brief_title>Insulin Therapy Reduce Post-Operative Inflammatory Response After Curative Colorectal Cancer Resection : Randomization Controlled Trial</brief_title>
	<detailed_description>Aim &amp; hypothesis : The aim investigate effect protocol colorectal surgery delineate effect perioperative inflammation , immunosuppression clinical outcome . This original approach , protocol never use bowel surgery . The hypothesis predict reduce inflammation result immunomodulation due anti-inflammatory effect hyper-insulinmic euglycimic infusion , improve postoperative morbidity oncological outcome . Study Design Participants : With approval ethic board King Saud University Medical city ( KSUMC ) triple blind randomize control study operable resectable CRC patient consent randomized receive hyperinsulinimic normoglycemic protocol ( experimental ) standardize insulin slide scale ( control ) . Sample Size estimation : 72 patient per group ( total 144 ) calculate sufficient detect reduction disease recurrence 35 20 percent , α=0•05 power 0.8 . Randomization : Computer generate randomization Blinding : Triple blind study . Patient keep blind group he/she assign . An independent anesthesia team manage infusion involve patient care study analysis . Research assistant collect data sample blind therapy . Patients ' follow primary surgeon also blind intervention . Analysis do blind group A &amp; B . Intervention : Intraoperative Intravenous insulin glucose . The anasthesia ask prepare insulin bag contain 1000 unit 1 liter normal saline , another bag dextrose 20 % 30 mmol KPO4/ liter supply pharmacy . In Experimental therapy group , obtain baseline preoperative blood glucose value , 2 U/kg bolus insulin administer IV follow infusion 2 mU/ kg/min . Ten minute start insulin infusion , blood glucose &lt; 6.1 mmol /L ( 110 mg /dL ) , dextrose 20 % supplement phosphate ( 30 mmol/L ) administer . In operating room , blood glucose level measure every 15 minute , dextrose infusion rate adjust maintain arterial glycemia 3.5 6.1 mmol/L ( 63-110 mg/dL ) , accord protocol . If Blood Glucose mg/dl Action &lt; 63 Stop insulin infusion.Give Dextrose 20 % 10 ml recheck level 10 minute 63.0 - 110 Maintain current infusion rate 111 - 143 144 - 180 Increase infusion 2 unit/hour &gt; 180 Increase infusion 3 unit/hour The blood glucose measure hourly 24 hour ICU , dextrose infusion rate modify attend nurse accord protocol ( attach ) . Regarding safety patient hyperinsulinemia arm glucocheck every 5-10 minute use arterial line . Ongoing dextrose 20 % + KPO4 supplementation glucocheck drop less 110 titrate aim maintain glucocheck 63-110 . If point time patient reach sever hypoglycemia define 32.3 ( 1.8 ) insulin drip stop patient consider dropout study . Resuscitation dextrose KPO4 continue achieve eu-glycemia . An international expert insulin clamp conduct first patient assure local team experience extra assurance . Glucose Level mg/dl 20 % Dextrose infusion + 30 meq Kcl &lt; 63 + 15 ml/h &amp; 20ml bolus &amp; Call MD 63-74 +10 ml/h &amp; 10 ml bolus 75-81 + 5ml/h 82-98 Maintain rate 99-110 - 5ml/h 111-116 -10ml/h &gt; 126 - 50 % current rate &amp; Call MD In standard therapy group , blood glucose measurement perform induction anesthesia , every 30 minute surgery , hourly ICU 24 hour . If blood glucose &gt; 6.1 mmol /L ( 110 mg /dL ) , insulin infusion 1 U/ h start . This titrate accord slide scale ( Attached ) , aim blood glucose 3.5 6.1 mmol / L ( 63-110 mg/dL ) surgery 3.5 7.9 mmol /L ( 63-143 mg /dL ) surgery A common preoperative postoperative pathway standardize management pain control implement group . In diabetic patient , administration oral hypoglycemic drug discontinue 24 hour surgery . If patient receive insulin , daily dose hold evening surgery , subcutaneous insulin administer use slide scale . Arterial blood glucose concentration measure use glucocheck . Human insulin administer use concentration 100 U insulin 100 mL normal saline . Assessments : Baseline preoperative investigation , 2 hour surgery day 1 post operative , day 3 , day 5 , 1 month postoperative assessment consist : Routine lab work - CBC differential , - Urea &amp; electrolyte . - Liver function test . Inflammatory assessment - TNF-alpha , - IL-8 , - IL-6 - IL-10 - IL-1β - IL-18 - IFNγ - MIP1α - MMP-8 - TGF beta - C-reactive protein The cytokine analysis do use suspension bead array immunoassay Luminex 200 X-map instrument ( Luminex Corp , Austin , TX , USA ) . Analysis cytokine carry use Milliplex human cytokine kit follow manufacturer 's specification ( MPXHCYTO-60k , Millipore Corp , Bilerica , MA , USA ) . All sample analyze duplicate kit sensitivity 0.4 pg/mL . Concentrations calculate standard curve generate MasterPlex QT 4.0 analysis software ( MiraiBio Inc , Alameda , CA , USA ) . Immunomodulation Quantity activity CD4 , CD8 , T-Cells T-cell profile - Activation - Proliferation - Functionality ( Intracellular cytokine profile ) . NK-Cells Profile - Proliferation - Activation *The degree perioperative inflammation dynamic process differs accord time . The number lab test intend build curve describe patient inflammatory response effect insulin . The cytokine analysis do research lab , test send hospital lab . The amount blood take limited test , OR blood take dedicated line prevent discard . The degree perioperative inflammation dynamic process differs accord time . The number lab test intend build curve describe patient inflammatory response effect insulin . Postoperative morbidity Postoperative event define grade per attached table . non-infectious morbidity : Morbidity Description Hyperglycemia &gt; 10 mmol/L Hypoglycemia &lt; 2 mmol/L PONV ( post operative nausea vomit ) Persistent beyond day 2 postoperative Bleeding Requiring surgical intervention Or Hemoglobin drop &gt; 4 mg/dL Cardiac event Symptomatic arrhythmia Blood troponin &gt; 0.5 , ECG change Pleural effusion Tapping require patient relief Abdominal Ascites : dyspnea leak abdominal wall Acute renal failure Serum creatinine &gt; 2 x upper limit normal Anastomotic Leak Radiological luminal contrast extravasation Clinical finding localize generalized peritonitis Feculent drainage drain Need urgent intervention Infectious morbidity : Morbidity Description Pneumonia Pneumonic atelactic change chest radiograph positive sputum culture Wound infection Erythema induration associate positive bacterial culture Intra-abdominal Collection pu abdomen without necrotic material Abscess associate positive bacterial culture Urinary tract infection Urinary symptom urine culture positive bacterial growth &gt; 105 colony form units/ml Central line sepsis Positive culture catheter tip &gt; 15 colony form unit presence febrile episode . Leakage Grading accord International study group rectal cancer ( ISREC ) Grade Type leak A Anastomotic leakage require active therapeutic intervention . B Anastomotic leakage require active therapeutic intervention manageable without laparotomy . C Anastomotic leakage require Laparotomy . Overall Morbidity grade Full Scale Grades Definition Grade I : Any deviation normal postoperative course without need pharmacological treatment surgical , endoscopic radiological intervention . Allowed therapeutic regimen : drug antiemetic , antipyretic , analgetics , diuretic electrolytes physiotherapy . This grade also include wound infection open bedside . Grade II : Requiring pharmacological treatment drug allow grade I complication . Blood transfusion total parenteral nutrition also include . Grade III : Requiring surgical , endoscopic radiological intervention Grade III-a : intervention general anesthesia Grade III-b : intervention general anesthesia Grade IV : Life-threatening complication ( include CNS complication ) ‡ require IC/ICU-management Grade IV-a : single organ dysfunction ( include dialysis ) Grade IV-b : multi organ dysfunction Grade V : Death patient Suffix 'd ' : If patient suffers complication time discharge , suffix `` '' ( 'disability ' ) add respective grade complication . This label indicate need follow-up fully evaluate complication . Survival outcome : As per guideline patient undergo routine colonoscopy 1 year depend result , also CT scan 1 year , 3 year 5 year . Data privacy management : In cardiac surgery mainly direct towards postoperative complication graft survival . In liver resection main outcome postoperative liver dysfunction micro mechanism relate glycogen storage might cause early faster hepatic recovery . In study , 's first time correlate anastomotic leak mainly oncological outcome . The use therapy make clinical side study need confirm efficacy .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Age &gt; 18 year Documented CRC histopathology Patient consent study refuse . Metastatic disease time diagnosis . Contraindications insulin Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>CRC-Insulin</keyword>
</DOC>